|Day Low/High||1.55 / 1.66|
|52 Wk Low/High||0.19 / 2.23|
Let's look at seven names that you can buy right now and watch grow.
This has given investors an opportunity to load up on small speculative names I love over the next 12 to 18 months.
There are much better places an investor can put their hard-earned cash, whether they want an aggressive or a moderate name.
The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations.
Dealmaking is going strong and looks set to continue as mental health becomes a key investment theme going forward.